GOLDMAN SACHS GROUP INC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$202,307
-37.4%
12,804
-40.0%
0.00%
Q2 2023$323,031
-52.8%
21,336
-54.8%
0.00%
Q1 2023$684,055
-87.4%
47,176
-88.3%
0.00%
-100.0%
Q4 2022$5,435,570
-23.4%
402,039
-10.7%
0.00%
-50.0%
Q3 2022$7,092,000
+30.7%
449,993
+1.0%
0.00%
+100.0%
Q2 2022$5,428,000
+29.8%
445,686
+0.1%
0.00%0.0%
Q1 2022$4,183,000
-45.1%
445,4550.0%0.00%
-50.0%
Q4 2021$7,626,000445,4550.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders